Lenvima (Lenvatinib) – Multiple Receptor Tyrosine Kinase (RTK) Inhibitor
In the absence of promising late stage programs that can potentially fill the revenue decline due to patent expiration of erstwhile blockbusters,...
214 Views
Takeda Pharmaceutical - Is M&A the Way Out of Its Problems?
The FT has reported that Takeda Pharmaceutical may be back on the acquisition trail, with a US$15bil war-chest. This puts into the public domain a...
312 Views